Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

Novo Nordisk A/S said a bigger dose of the main ingredient in Wegovy, its top-selling weight-loss drug, helped patients shed ...

Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

During a roughly five-year span, CVS Health, Cigna, and UnitedHealth benefited the most from increasing prices for generic drugs that treated illnesses such as HIV and cancer. Some of the price hikes ...

Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in ...

President-elect Donald Trump has not backed down from insisting that the United States needs to acquire Greenland, a Danish ...

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

This was a five-year longitudinal cohort study (2018–2024) which identified all individuals with T2D in Denmark (n = 424,152). The cohort was stratified into two groups: • Semaglutide exposure group: ...

Building on these findings, a new preprint study from Denmark and Norway has reaffirmed the association ... which included 16,000 people. Semaglutide is widely used to treat type 2 diabetes and ...

Two large studies from the University of Southern Denmark suggest that the diabetes ... among users of semaglutide than among users of other antidiabetic medications. This finding is very ...